Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 February 2022 | Story Leonie Bolleurs and Rulanzen Martin

After two years of lockdown, online meetings, and limited contact with colleagues, academy at the University of the Free State (UFS) is gradually returning to normal. This month (February 2022), staff, students, and members of related industries will convene on three different occasions to learn about cutting-edge scholarship, to reconnect with each other, and to discuss issues impacting society in the fields of theology, the humanities, and agriculture.

Seminar on ‘The Limits of Decolonisation’ with Prof RW Johnson 

Date: 24 February 2022
Time: 09:00-16:00 SAST
Venue/Platform: Equitas Auditorium, UFS Bloemfontein Campus, and Microsoft Teams 
Microsoft Teams link: https://bit.ly/3Llejew 

Decolonisation has been a heated point of discussion for some time now, but have you ever wondered if there could be limitations hindering the decolonisation project?  The Departments of Political Studies and Governance and Philosophy and Classics at the UFS will host an array of academics and experts for a hybrid seminar on the topic The Limits of Decolonisation.

If decolonisation is an important issue for you or if you are interested in the topic and its relevance and influence in the world and academia, you should join or attend the seminar – either online via Microsoft Teams or in person in the Equitas Auditorium – on 24 February 2022 from 09:00. 

The keynote speaker is political scientist Prof RW Johnson from the University of Oxford. Prof Johnson is an emeritus fellow at Magdalen College and is the author of several acclaimed political books.  The other speakers are all from the Departments of Political Studies and Governance, and Philosophy and Classics. Terrence Corrigan from the South African Institute of Race Relations will speak on The relationship between critical race theory and decolonisation. 

Find full programme here

RSVP: Alice Stander StanderAFM@ufs.ac.za  (please specify dietary requirements, as a light lunch will be served) 


 

 

 

 

 

 

 

 

 

 

 

 

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept